AKRX Stock Price, News & Analysis
AKRX
NASDAQ
Company Description
AKRX (NASDAQ: AKRX) is a publicly traded pharmaceuticals: major company in the Health Technology sector.
AKRX stock has declined 97.8% over the past year.
This page provides a comprehensive overview of AKRX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
$—
0.00%
0.00
Last updated:
-97.8%
Performance 1 year
$0.0
AKRX (AKRX) stock. Over the past 12 months, the stock has lost 97.8%.
Latest News
AKRX has 1 recent news article. Key topics include fda approval. View all AKRX news →
SEC Filings
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Operating Cash Flow
Upcoming Events
Short Interest History
Last 12 Months
Days to Cover History
Last 12 Months
AKRX Company Profile & Sector Positioning
AKRX (AKRX) operates in the Pharmaceuticals: Major industry within the broader Health Technology sector and is listed on the NASDAQ.